Trifluoperazine effect on human sperm: the accumulation of reactive oxygen species and the decrease in the mitochondrial membrane potential.

Drug repurposing Human semen quality In vitro Intracellular calcium concentration Trifluoperazine

Journal

Reproductive toxicology (Elmsford, N.Y.)
ISSN: 1873-1708
Titre abrégé: Reprod Toxicol
Pays: United States
ID NLM: 8803591

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 23 07 2024
revised: 05 09 2024
accepted: 30 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 6 10 2024
Statut: aheadofprint

Résumé

A strong link between antipsychotic drug use and reduced human sperm quality has been reported. Trifluoperazine (TFP), a commonly used antipsychotic, is now being explored for anticancer applications. Although there are hints that TFP might affect the male reproductive system, its impact on human sperm quality remains uncertain. Using a human sperm and TFP in vitro coculture system, we examined the effect of TFP (12.5, 25, 50 and 100μM) on human sperm function and physiological parameters. The results showed that 50μM and 100μM TFP induced the accumulation of reactive oxygen species (ROS) and a decrease in the mitochondrial membrane potential (MMP) of human sperm, leading to decreased sperm viability, while 25μM TFP inhibited only the penetration ability, total sperm motility, and progressive motility. Although 12.5μM and 25μM TFP increased [Ca

Identifiants

pubmed: 39369966
pii: S0890-6238(24)00197-7
doi: 10.1016/j.reprotox.2024.108730
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108730

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Houpeng Wang (H)

School of Public Health, Jiangxi Medical College, Nanchang University; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Jiangxi Medical College, Nanchang University, Nanchang 330006, People's Republic of China.

Cheng Cheng (C)

School of Basic Medical Sciences and Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China.

Jing Ding (J)

School of Basic Medical Sciences and Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China.

Ruirui Qian (R)

School of Basic Medical Sciences and Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China.

Tao Luo (T)

School of Basic Medical Sciences and Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China.

Liping Zheng (L)

School of Public Health, Jiangxi Medical College, Nanchang University; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Jiangxi Medical College, Nanchang University, Nanchang 330006, People's Republic of China. Electronic address: zhengliping@ncu.edu.cn.

Ying Chen (Y)

School of Basic Medical Sciences and Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China. Electronic address: chenying26@ncu.edu.cn.

Classifications MeSH